Not using Bio­strength for BE [Regulatives / Guidelines]

posted by jag009  – NJ, 2018-07-17 08:32 (1903 d 02:47 ago) – Posting: # 19073
Views: 2,127


❝ Our firm is developing a multi-strength product which is a high potency, NTI oral dosage...

1) Is 0.15mg your only strength?
2) Why you want to dose 0.15x4 and not just 0.15mg?
3) Better to file a control correspondence


Complete thread:

UA Flag
 Admin contact
22,763 posts in 4,775 threads, 1,628 registered users;
13 visitors (0 registered, 13 guests [including 2 identified bots]).
Forum time: 11:20 CEST (Europe/Vienna)

The object of statistics is information.
The objective of statistics is the understanding of information
contained in data.    Irwin and Marylees Miller

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz